Structured delivery. Controlled manufacturing. Accelerated time to market.
High-quality, stability-tested, proven liposomal formulations available for rapid commercial launch
GMPriority Pharma provides white label liposomal products for brands seeking technically credible, stability-tested formulations manufactured within controlled GMP environments.
Our white label route enables rapid market entry without compromising the structural integrity or analytical rigour expected of advanced liposomal systems.
All products are manufactured in-house in the UK using established liposomal processing protocols, ensuring consistency, reproducibility and long-term supply reliability.
White label programmes are delivered within a structured manufacturing framework, providing:
Unlike generic white label products, GMPriority Pharma formulations are developed using a delivery-first framework that aligns lipid structure, particle behaviour and processing conditions.
Structurally Consistent
Stability-Tested
Reproducible at Scale
Liposomal systems are sensitive to formulation and processing variables. White label products from GMPriority Pharma are developed with defined control over these parameters to provide consistent particle size distribution, stable dispersion behaviour and reproducible batch output.
This enables reliable product performance across manufacturing cycles and future supply batches.
Formulations are available across a range of active categories, including:
Available in liquid, capsule and powder format.
Availability and minimum order volumes vary by product category and packaging configuration.
All white label products are produced within GMP-certified, FSSC ISO 22000-accredited facilities, with defined process control and quality frameworks.
Each production batch follows defined processing parameters to maintain particle size consistency, dispersion stability and structural integrity.
White label is suited to companies that require speed to market without sacrificing technical credibility.
This route allows brands to focus on positioning, marketing and distribution, while GMPriority Pharma delivers controlled liposomal manufacturing within defined, repeatable quality parameters.
The result is faster product launch with reduced technical risk.
Structured production process
Defined quality systems
Reliable batch manufacturing
Technical transparency
White label programmes operate within defined commercial frameworks, supporting:
GMPriority Pharma’s white label programmes provide a structured, controlled route to market, combining delivery science, manufacturing discipline and commercial readiness.